Operating Income Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual operating income in 2023 was 141.71 Million TWD , down -30.86% from previous year.
Apex Biotechnology Corp.'s latest quarterly operating income in 2024 Q2 was 16.99 Million TWD , up 3.82% from previous quarter.
Apex Biotechnology Corp. reported an annual operating income of 204.97 Million TWD in 2022, up 5.67% from previous year.
Apex Biotechnology Corp. reported an annual operating income of 193.97 Million TWD in 2021, up 60.93% from previous year.
Apex Biotechnology Corp. reported a quarterly operating income of 16.37 Million TWD for 2024 Q1, down -57.28% from previous quarter.
Apex Biotechnology Corp. reported a quarterly operating income of 38.33 Million TWD for 2023 Q4, down -22.34% from previous quarter.

Annual Operating Income Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Operating Income of Apex Biotechnology Corp. (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	141.71 Million TWD	-30.86%
2022	204.97 Million TWD	5.67%
2021	193.97 Million TWD	60.93%
2020	120.52 Million TWD	-30.29%
2019	172.9 Million TWD	-23.95%
2018	227.34 Million TWD	41.21%
2017	160.99 Million TWD	-34.52%
2016	245.88 Million TWD	-18.25%
2015	300.79 Million TWD	3.91%
2014	289.48 Million TWD	-17.05%
2013	348.99 Million TWD	-42.09%
2012	602.59 Million TWD	8.06%
2011	557.63 Million TWD	-2.85%
2010	574.02 Million TWD	27.71%
2009	449.46 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	16.99 Million TWD	3.82%
2024 Q1	16.37 Million TWD	-57.28%
2023 Q4	38.33 Million TWD	-22.34%
2023 Q2	34.42 Million TWD	-28.7%
2023 FY	141.71 Million TWD	-30.86%
2023 Q1	48.27 Million TWD	9.0%
2023 Q3	49.35 Million TWD	43.39%
2022 Q3	72.5 Million TWD	153.35%
2022 FY	204.97 Million TWD	5.67%
2022 Q1	59.55 Million TWD	0.06%
2022 Q4	44.29 Million TWD	-38.91%
2022 Q2	28.61 Million TWD	-51.95%
2021 FY	193.97 Million TWD	60.93%
2021 Q3	57.14 Million TWD	53.14%
2021 Q1	62.27 Million TWD	138.17%
2021 Q4	59.52 Million TWD	4.16%
2021 Q2	37.31 Million TWD	-40.08%
2020 Q2	32.04 Million TWD	112.38%
2020 Q1	15.08 Million TWD	-88.85%
2020 Q4	26.14 Million TWD	-11.95%
2020 FY	120.52 Million TWD	-30.29%
2020 Q3	29.69 Million TWD	-7.33%
2019 Q3	3.2 Million TWD	-89.45%
2019 FY	172.9 Million TWD	-23.95%
2019 Q1	34.66 Million TWD	-28.67%
2019 Q2	30.4 Million TWD	-12.29%
2019 Q4	135.34 Million TWD	4120.24%
2018 Q2	33.07 Million TWD	-26.02%
2018 FY	227.34 Million TWD	41.21%
2018 Q3	100.98 Million TWD	205.37%
2018 Q1	44.7 Million TWD	-43.67%
2018 Q4	48.59 Million TWD	-51.88%
2017 Q4	79.35 Million TWD	212.44%
2017 Q1	14.65 Million TWD	-55.65%
2017 Q3	25.39 Million TWD	-38.93%
2017 FY	160.99 Million TWD	-34.52%
2017 Q2	41.59 Million TWD	183.81%
2016 Q4	33.03 Million TWD	-7.31%
2016 FY	245.88 Million TWD	-18.25%
2016 Q1	98.48 Million TWD	-2.86%
2016 Q2	78.72 Million TWD	-20.06%
2016 Q3	35.64 Million TWD	-54.73%
2015 Q3	82.55 Million TWD	53.47%
2015 FY	300.79 Million TWD	3.91%
2015 Q1	63.07 Million TWD	-16.66%
2015 Q2	53.79 Million TWD	-14.72%
2015 Q4	101.37 Million TWD	22.8%
2014 Q1	59.89 Million TWD	22.87%
2014 Q4	75.68 Million TWD	10.63%
2014 Q3	68.41 Million TWD	-19.99%
2014 Q2	85.49 Million TWD	42.74%
2014 FY	289.48 Million TWD	-17.05%
2013 Q3	67.92 Million TWD	-39.96%
2013 Q4	48.74 Million TWD	-28.23%
2013 FY	348.99 Million TWD	-42.09%
2013 Q1	119.2 Million TWD	-13.26%
2013 Q2	113.12 Million TWD	-5.1%
2012 Q2	146.21 Million TWD	-20.86%
2012 FY	602.59 Million TWD	8.06%
2012 Q3	137.23 Million TWD	-6.15%
2012 Q1	184.76 Million TWD	6.45%
2012 Q4	137.43 Million TWD	0.14%
2011 Q4	173.56 Million TWD	7.56%
2011 Q1	102.58 Million TWD	-28.41%
2011 Q3	161.36 Million TWD	34.33%
2011 FY	557.63 Million TWD	-2.85%
2011 Q2	120.12 Million TWD	17.1%
2010 Q2	143.72 Million TWD	11.79%
2010 Q4	143.3 Million TWD	-9.55%
2010 Q1	128.56 Million TWD	0.0%
2010 FY	574.02 Million TWD	27.71%
2010 Q3	158.43 Million TWD	10.24%
2009 FY	449.46 Million TWD	0.0%

Peer Operating Income Comparison of Apex Biotechnology Corp.

Name	Operating Income	Operating Income Difference
Sinphar Pharmaceutical Co.,Ltd.	286.05 Million TWD	50.459%
Panion & Bf Biotech Inc.	156.82 Million TWD	9.637%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	280.8 Million TWD	49.533%
GenMont Biotech Incorporation	6.98 Million TWD	-1927.991%
Abnova (Taiwan) Corporation	47.19 Million TWD	-200.284%
Adimmune Corporation	-722.74 Million TWD	119.608%
Tanvex BioPharma, Inc.	-2.1 Billion TWD	106.746%
Polaris Group	-1.84 Billion TWD	107.673%
Energenesis Biomedical CO.,LTD.	-261.83 Million TWD	154.124%
UnicoCell Biomed Co., Ltd.	-96.28 Million TWD	247.192%
PELL Bio-Med Technology Co. Ltd.	-411.24 Million TWD	134.46%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Operating Income Summary of Apex Biotechnology Corp.

Annual Operating Income Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Operating Income of Apex Biotechnology Corp. (2023 - 2009)

Peer Operating Income Comparison of Apex Biotechnology Corp.